Carina Biotech
Suzanne Ridding is a distinguished founder and principal consultant at Sustainable Business Consultants since 2008, specializing in sustainability, carbon, and climate resilience consultancy. With extensive experience across private, public, and not-for-profit sectors, Suzanne has held various leadership roles including sustainability manager at StatewideSuper and chief financial officer at TransAdelaide. Notably, Suzanne has contributed to the governance of organizations as a board member and chair at Nature Foundation SA and as an independent member of the audit and risk committee at Carina Biotech. Education includes an MBA in Sustainable Business from the University of South Australia and banking qualifications from the Association of Chartered Bankers UK.
This person is not in any teams
Carina Biotech
Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.